Clinical trial
Analgesic Treatment Mediated by Arcoxia (0663-093)
NCT00380523 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00380523 |
|---|---|
| Title | Analgesic Treatment Mediated by Arcoxia (0663-093) |
| Official title | Analgesic Treatment Mediated by Arcoxia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days |
| Enrollment | 237 |
| Start date | Apr 1, 2005 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 26, 2006 |
| Last update posted | Feb 16, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: